Axelyf, Inc.
PrivateLast Round
Seed
Aug 19, 2025
Total Funding Raised
$2.6M
Company Overview
Axelyf, Inc. is a biotechnology company developing RNA therapeutics for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axelyf, Inc. Comparables
Compare Axelyf, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hopewell Therapeutics | 88% | |
| NanoVation Therapeutics | 84% | |
| Mana.bio | 82% |
Axelyf, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 19, 2025 |
Key People
Founding team and executive leadership
Axelyf, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brunnur Ventures | Seed |
| Omega ehf | Seed |
| Silfurberg ehf | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
Grew 27% QoQ, from 11 to 14 employees.
- Aug 29, 2025
Árni Blöndal, Founding Partner of Brunnur Ventures, joined the board.
Axelyf, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Axelyf, Inc.'s valuation, stock price, and market status.
Is Axelyf, Inc. a public or private company?
Axelyf, Inc. is a private company.
What is the current stock price of Axelyf, Inc.?
Axelyf, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Axelyf, Inc. worth (valuation)?
Valuation information for Axelyf, Inc. is not publicly available.
Can I buy Axelyf, Inc. stock?
Axelyf, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Axelyf, Inc.'s last funding round?
Axelyf, Inc.'s most recent funding round was Seed on August 19, 2025.
Who are the main investors in Axelyf, Inc.?
Key investors in Axelyf, Inc. include Brunnur Ventures.
Will Axelyf, Inc. IPO soon?
No public IPO plans have been announced for Axelyf, Inc..
How can I track Axelyf, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axelyf, Inc.'s secondary market activity and sign up for updates.